ArticleOpen forum infectious diseases2025

Interest in Long-Acting Preexposure Prophylaxis (PrEP) Among Men at Risk for Human Immunodeficiency Virus Who Use Methamphetamine Participating in a Daily, Oral PrEP Adherence Trial in San Francisco, California.

Vanessa M McMahan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.